Edition:
United States

HTG Molecular Diagnostics Inc (HTGM.OQ)

HTGM.OQ on NASDAQ Stock Exchange Capital Market

5.06USD
16 Feb 2018
Change (% chg)

$0.01 (+0.20%)
Prev Close
$5.05
Open
$4.90
Day's High
$5.46
Day's Low
$4.76
Volume
278,127
Avg. Vol
224,077
52-wk High
$13.24
52-wk Low
$1.20

Latest Key Developments (Source: Significant Developments)

HTG Molecular Diagnostics Intends To Offer 10 mln shares of common stock
Tuesday, 16 Jan 2018 04:01pm EST 

Jan 16 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK.HTG MOLECULAR DIAGNOSTICS - ‍INTENDS TO OFFER AND SELL, 10 MILLION SHARES OF COMMON STOCK IN UNDERWRITTEN PUBLIC OFFERING​.  Full Article

HTG Announces Preliminary Q4 And Full Year 2017 Unaudited Financial Results
Thursday, 4 Jan 2018 08:00am EST 

Jan 4 (Reuters) - HTG Molecular Diagnostics Inc ::HTG ANNOUNCES PRELIMINARY FOURTH QUARTER AND FULL YEAR 2017 UNAUDITED FINANCIAL RESULTS AND PROVIDES INITIAL 2018 REVENUE GUIDANCE.SEES Q4 2017 REVENUE $6.9 MILLION TO $7.2 MILLION.SEES FY 2017 REVENUE $13.8 MILLION TO $14.1 MILLION.SEES FY 2018 REVENUE $20 MILLION TO $25 MILLION.  Full Article

HTG Molecular, Illumina Agreed To Third Development Plan Under Parties' Amended & Restated Development & Supply Agreement
Wednesday, 27 Dec 2017 04:35pm EST 

Dec 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC 23, CO, ILLUMINA AGREED TO THIRD DEVELOPMENT PLAN UNDER PARTIES' AMENDED & RESTATED DEVELOPMENT & SUPPLY AGREEMENT.HTG MOLECULAR DIAGNOSTICS SAYS UNDER PLAN, ILLUMINA EXPECTED TO DEVELOP & DELIVER TO CO EXECUTABLE VERSION OF CUSTOM SOFTWARE - SEC FILING.  Full Article

HTG Molecular Diagnostics Expands Its Collaboration With Merck
Tuesday, 26 Dec 2017 04:01pm EST 

Dec 26 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS EXPANDS ITS COLLABORATION WITH MERCK KGAA, DARMSTADT, GERMANY.HTG MOLECULAR - TO DEVELOP CUSTOM PROFILING ASSAY TO SUPPORT BIOMARKER RESEARCH FOR 6 INDICATIONS WITHIN MERCK KGAA'S DRUG DEVELOPMENT PIPELINE.  Full Article

HTG Molecular Diagnostics And Unit Of QIAGEN Amended First Statement Of Work Under Master Agreement
Wednesday, 20 Dec 2017 08:17am EST 

Dec 20 (Reuters) - Htg Molecular Diagnostics Inc ::HTG MOLECULAR DIAGNOSTICS - ON DEC. 18. CO, UNIT OF QIAGEN, AMENDED FIRST STATEMENT OF WORK UNDER MASTER AGREEMENT - SEC FILING.HTG MOLECULAR DIAGNOSTICS - UNDER AGREEMENT, QIAGEN AGREED TO PAY CO LOW, SINGLE‑DIGIT MILLIONS OF DOLLARS FOR NEXT‑PHASE ACTIVITIES FOR PROJECT.  Full Article

HTG Molecular Diagnostics reports third quarter earnings
Tuesday, 7 Nov 2017 04:05pm EST 

Nov 7 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports 2017 third quarter earnings.Q3 loss per share $0.46.Sees FY 2017 revenue $10 million to $13 million.Q3 revenue $3.7 million.  Full Article

HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​
Monday, 18 Sep 2017 08:00am EDT 

Sept 18 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics Inc - ‍HTG Molecular Diagnostics receives ISO 13485 certification for Health Canada CMDCAS requirements​.  Full Article

HTG Molecular Diagnostics Q2 loss per share $0.60
Tuesday, 8 Aug 2017 04:01pm EDT 

Aug 8 (Reuters) - Htg Molecular Diagnostics Inc :HTG Molecular Diagnostics reports second quarter 2017 results.Q2 loss per share $0.60.Q2 revenue $1.8 million.Sees FY 2017 revenue $9.0 million to $12 million.  Full Article

HTG Molecular Diagnostics initiates second development program under co's master agreement with unit of Qiagen N.V.
Thursday, 27 Jul 2017 09:00am EDT 

July 27 (Reuters) - HTG Molecular Diagnostics Inc ::HTG Molecular Diagnostics - initiation of second development program under co's master agreement with unit of Qiagen N.V..  Full Article

Novo Holdings reports 12.03 pct stake in HTG Molecular Diagnostics as on July 3
Thursday, 20 Jul 2017 06:22am EDT 

July 20 (Reuters) - Htg Molecular Diagnostics Inc -:Novo Holdings A/S reports 12.03 percent stake in HTG Molecular Diagnostics Inc as on July 3, 2017 - sec filing‍​.Novo Holdings A/S had previously reported 15.9 percent stake in HTG Molecular Diagnostics Inc as on March 23, 2017 - sec filing‍​.  Full Article

BRIEF-Stonepine Capital Management Reports 5.6 Pct Passive Stake In HTG Molecular Diagnostics

* STONEPINE CAPITAL MANAGEMENT LLC REPORTS A 5.6 PERCENT PASSIVE STAKE IN HTG MOLECULAR DIAGNOSTICS INC AS OF JANUARY 19 - SEC FILING Source text - http://bit.ly/2G2Dlxg Further company coverage: